How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €427.95 | €501.09 |
| Amazon.com Inc. | €226.95 | €258.70 |
| Intuitive Surgical Inc | €340.85 | €507.75 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €91.38 | €91.19 |
| Western Union Co. | €6.44 | €7.01 |
| Defsec Technologies Inc. | €2.54 | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B FutureFuel Corp. | Traumtanz | 25.73% |
| B Innovate Corp. | daimler1 | 21.24% |
| B Tenax Therapeutics Inc. | daimler1 | 19.08% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Socket Mobile Inc. | Bankster | -52.62% |
| S Socket Mobile Inc. | Lokrim | -32.77% |
| S Capricor Therapeutics Inc | Bankster | -25.80% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Space X
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Socket Mobile Inc.
WKN: A0RBSN / Name: Socket Mobile / Stock / Computers, Phones & Household Electronics / Micro Cap /
Pros
Cons
Enlivex Therapeutics Ltd.
WKN: A119KH / Name: Enlivex Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Copart Inc. | €27.30 | 6.980% |
| Sandisk Corp. | €1,430.0 | 6.770% |
| Newmont Corp. | €102.50 | 6.190% |
| Advanced Micro Devices Inc. | €444.20 | 6.000% |
| Carnival Paired Ctf | €23.45 | 5.850% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Broadcom Ltd. | €339.75 | -6.460% |
| Applied Materials Inc. | €438.35 | -5.640% |
| Workday, Inc. | €171.74 | -4.560% |
| HP Inc. | €26.03 | -4.230% |
| CrowdStrike Holdings Inc | €187.50 | -4.220% |
Courses
Key figures for stocks
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Predictions
Lumentum Holdings Inc
08:35
14.08.26
Ast Spacemobile Inc.
08:35
14.08.26
Sandisk Corp.
08:29
14.08.26
Bloom Energy Corp
08:28
14.08.26
Top News
onsemi Boosts Utilization as AI Data Center Revenue Set to More Than Double
Key Points
- Interested in onsemi? Here are five stocks we like better.
- AI data center revenue is expected to more than double to over $500 million this year from approximately $250 million last
Universal Display Sees $20B OLED Capacity Wave Powering Long-Term Growth
Key Points
- Interested in Universal Display Corporation? Here are five stocks we like better.
- OLED manufacturers have committed more than $20 billion to new capacity, including Gen 8.6 fabs
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Key Points
- Interested in Orthofix Medical Inc.? Here are five stocks we like better.
- Orthofix restored its bone growth stimulation reimbursement, allowing it to recoup roughly $1 million lost
Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts
Key Points
- Interested in Ocugen, Inc.? Here are five stocks we like better.
- Ocugen is targeting 2027 BLA filings for its OCU400 retinitis pigmentosa and OCU410ST Stargardt disease gene
NXP Semiconductors Sees Demand Rebound as Auto, AI and Data Center Growth Accelerate
Key Points
- Interested in NXP Semiconductors N.V.? Here are five stocks we like better.
- Demand is rebounding across NXP’s markets: Book-to-bill ratios are above one, distribution inventory has
NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates
NRx Pharmaceuticals, Inc. (NRXP) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.98 per share a year ago
Flexible Solutions International Inc. (FSI) Reports Q2 Loss, Misses Revenue Estimates
Flexible Solutions International Inc. (FSI) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.15 per share a year ago
This Dividend Aristocrat Posted Record Quarterly Results
Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.
And when considering
Barfresh Food Group Inc. (BRFH) Reports Q2 Loss, Lags Revenue Estimates
Barfresh Food Group Inc. (BRFH) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.06 per share a year ago. These
Prairie Operating Co. (PROP) Q2 Earnings Top Estimates
Prairie Operating Co. (PROP) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.18 per share a year ago
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference
Key Points
- Interested in Natera, Inc.? Here are five stocks we like better.
- Natera raised its outlook after broad-based second-quarter momentum, including record Signatera volumes, strong
News
Insight Enterprises Bets on AI Infrastructure, Services and Leaner Operations
Key Points
- Interested in Insight Enterprises, Inc.? Here are five stocks we like better.
- AI infrastructure and services are central to Insight’s three-year “One Insight” plan. The company
Terra Innovatum Targets 2027 Illinois Debut for SOLO Microreactor
Key Points
- Interested in Terra Innovatum Global S.R.L.? Here are five stocks we like better.
- Terra Innovatum is targeting late 2027 for the first deployment of its 1-megawatt SOLO microreactor
Nexxen International Bets on CTV, AI as Record Growth Prompts Another Outlook Raise
Key Points
- Interested in Nexxen International Ltd. Sponsored ADR? Here are five stocks we like better.
- Nexxen raised its full-year outlook for the third time, now expecting 12% net revenue
NioCorp’s Elk Creek Study Sees $4.1B NPV, 40-Year Critical Minerals Mine
Key Points
- Interested in NioCorp Developments Ltd.? Here are five stocks we like better.
- Updated economics: NioCorp’s Elk Creek study projects a $4.1 billion pre-tax NPV, $1.85 billion in
Nature’s Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth Push
Key Points
- Interested in Nature's Sunshine Products, Inc.? Here are five stocks we like better.
- Nature’s Sunshine is targeting $1 billion in sales and a 15% EBITDA margin, up from $480 million
Everspin Tech Targets $100M Revenue by 2029 With MRAM Expansion, Foundry Push
Key Points
- Interested in Everspin Tech? Here are five stocks we like better.
- Everspin targets more than $100 million in annual revenue by fiscal 2029, up from roughly $50 million–$55 million
Applied Materials Beat Everything but Wall Street’s Expectations for Margins
Key Points
- Interested in Applied Materials, Inc.? Here are five stocks we like better.
- Applied Materials delivered record quarterly revenue of $9.12 billion, including the highest sequential
Monro Muffler Brake Shareholders Elect Eight Directors, Back Pay and PwC Ratification
Key Points
- Interested in Monro Muffler Brake, Inc.? Here are five stocks we like better.
- Monro Muffler Brake shareholders elected all eight board nominees, who will serve until the 2027 annual
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage
Key Points
- Interested in Merit Medical Systems, Inc.? Here are five stocks we like better.
- Merit Medical is completing its current long-range plan while developing a new three-year strategy
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobieren
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.